Obinutuzumab in Combination With GDP Chemotherapy in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma
University Health Network, Toronto
University Health Network, Toronto
University of Nebraska
University of Maryland, Baltimore
M.D. Anderson Cancer Center
Montefiore Medical Center
The University of Hong Kong
Weill Medical College of Cornell University
Alliance for Clinical Trials in Oncology
Scripps Health
Temple University
Royal Marsden NHS Foundation Trust
Keio University